MARLYN JULES: Open Payments
NPI 1184947772 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 45 payments from 12 companies in 2025. Trend: 2023 $952 · 2024 $1,118 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $291 |
| Vanda Pharmaceuticals Inc. | 4 | $129 |
| Indivior Inc. | 4 | $116 |
| Braeburn Inc. | 6 | $115 |
| ABBVIE INC. | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Axsome Therapeutics, Inc. | 2 | $70 |
| Orexo US, Inc. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Alkermes, Inc. | 2 | $46 |
Products named: CAPLYTA, FANAPT, SUBLOCADE, BRIXADI, VRAYLAR, REXULTI, Auvelity, Zubsolv.
Industry payments across MA — which companies pay providers there.
